Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

NCT00719888

Conditions
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +65 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis

NCT00724334

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Investigational Site Number 840103 La Jolla, California, United States
  • Investigational Site Number 840102 Stanford, California, United States
  • Investigational Site Number 840105 Boston, Massachusetts, United States
  • Investigational Site Number 840106 Ann Arbor, Michigan, United States
View Trial Details
Completed

Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly

NCT01692366

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Investigational Site Number 392010 Akita, Japan
  • Investigational Site Number 392002 Bunkyō City, Japan
  • Investigational Site Number 392006 Bunkyō City, Japan
  • Investigational Site Number 392004 Sendai, Japan
View Trial Details
Completed

A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase

NCT04126681

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center Guangzhou, Gongdong, China
  • Nanfang hospital of southern medical university Guangzhou, Guangdong, China
  • Shenzhen Second People's Hospital Shenzhen, Guangdong, China
View all 22 locations
View Trial Details
Completed

Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation

NCT04281498

Conditions
Accelerated/Blast-phase Myeloproliferative Neoplasm, Bone Marrow Diseases, Chronic-phase Myelofibrosis, +5 more
Locations
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
View Trial Details
Completed

Tagraxofusp (SL-401) in Participants With Chronic Myelomonocytic Leukemia (CMML) and Myelofibrosis (MF)

NCT02268253

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +14 more
Locations
  • University of California, San Francisco Clovis, California, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Stanford Cancer Institute Stanford, California, United States
View all 24 locations
View Trial Details

Related conditions